- CEO
- Nezar Mohammed Sultan Bahabri
- Full Time Employees
- 4,322
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- 4, Batterjee Road Jeddah MC Saudi Arabia 21461
- IPO Date
- Mar 29, 2016
- Business
- Middle East Healthcare Company (4009.SR), also known as Saudi German Health, operates a network of multi-specialty tertiary care hospitals, clinics, medical education facilities, rehabilitation and physiotherapy centers, laboratories, radiology centers, and pharmacies across the Middle East and North Africa. The company provides comprehensive inpatient and outpatient services, including anesthesiology, anorectal laser clinics, audiology, cardiac care, chest clinics, chiropractic care, dental centers, emergency departments, gastroenterology, ophthalmology, oral and maxillofacial surgery, pediatric intensive care, and pharmacy sales; it manages key facilities such as Saudi German Hospital Jeddah (218 beds), Saudi German Hospital-Aseer (400 beds), Saudi German Hospital-Riyadh (300 beds), Saudi German Hospital-Madinah (300 beds), Saudi German Hospital-Hail (150 beds), Saudi German Hospital-Dammam (150-300 beds), Saudi German Hospital-Sanaa (300 beds), Saudi German Hospital-Dubai (300 beds), and Saudi German Hospital-Sharjah, along with standalone clinics like Beverly Clinics and operations in Egypt, Morocco, and Pakistan. Founded in 1988 by brothers Eng. Sobhi Batterjee and Dr. Khalid Batterjee and headquartered in Jeddah, Saudi Arabia, the group serves approximately 2.5 million patients annually through over 8,500 healthcare professionals, with a focus on advanced treatments via partnerships with German, US, UK, and Canadian providers, including Mayo Clinic Care Network affiliations for its Cairo and Riyadh hospitals. Recent developments include a 2020 rebranding from Saudi German Hospitals Group to Saudi German Health to consolidate its expanded ecosystem of hospitals, clinics, pharmacies, and education under one brand; launches of new facilities such as Saudi German Hospital Dammam and Ajman in 2019, clinics in Abha and a branch in Makkah in 2022, and Al Jami`ah District branch in Jeddah in 2021; a November 2025 board resolution to repurchase sukuk with ongoing updates; and a November 2025 fine for securities listing rules violation, alongside sustained revenue growth to SAR 3.04 billion (TTM) driven by segment expansion in Saudi Arabia, UAE, Yemen, and beyond.[][][]